{"id":"https://openalex.org/W4361847928","doi":"https://doi.org/10.1158/0008-5472.22403250","title":"Supplementary Figure Legends from Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel","display_name":"Supplementary Figure Legends from Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361847928","doi":"https://doi.org/10.1158/0008-5472.22403250"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22403250","doi":"https://doi.org/10.1158/0008-5472.22403250","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22403250","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legends_from_Influence_of_Drug_Formulation_on_OATP1B-Mediated_Transport_of_Paclitaxel/22403250/1/files/39849054.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legends_from_Influence_of_Drug_Formulation_on_OATP1B-Mediated_Transport_of_Paclitaxel/22403250/1/files/39849054.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031865542","display_name":"Annemieke J.M. Nieuweboer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annemieke J.M. Nieuweboer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077955893","display_name":"Shuiying Hu","orcid":"https://orcid.org/0000-0002-9806-7734","observed_orcids":["https://orcid.org/0000-0002-9806-7734"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuiying Hu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020579044","display_name":"Chunshan Gui","orcid":"https://orcid.org/0000-0001-9296-0911","observed_orcids":["https://orcid.org/0000-0001-9296-0911"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chunshan Gui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073680043","display_name":"Bruno Hagenbuch","orcid":"https://orcid.org/0000-0002-2938-8630","observed_orcids":["https://orcid.org/0000-0002-2938-8630"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruno Hagenbuch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033013240","display_name":"Inge M. Ghobadi Moghaddam-Helmantel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Inge M. Ghobadi Moghaddam-Helmantel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068080699","display_name":"Alice A. Gibson","orcid":"https://orcid.org/0000-0001-5910-5067","observed_orcids":["https://orcid.org/0000-0001-5910-5067"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alice A. Gibson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047240860","display_name":"Peter de Bruijn","orcid":"https://orcid.org/0000-0003-3372-5756","observed_orcids":["https://orcid.org/0000-0003-3372-5756"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter de Bruijn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074174053","display_name":"Ron H.J. Mathijssen","orcid":"https://orcid.org/0000-0001-5667-5697","observed_orcids":["https://orcid.org/0000-0001-5667-5697"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ron H.J. Mathijssen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5065279964","display_name":"Alex Sparreboom","orcid":"https://orcid.org/0000-0003-2660-6644","observed_orcids":["https://orcid.org/0000-0003-2660-6644"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Sparreboom","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oatp1b","display_name":"OATP1B","score":0.8709999918937683},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9819999933242798},{"id":"https://openalex.org/keywords/pharmaceutical-formulations","display_name":"drug formulation","score":0.8849999904632568},{"id":"https://openalex.org/keywords/drug-transport","display_name":"drug transport","score":0.6399999856948853},{"id":"https://openalex.org/keywords/organic-anion-transporting-polypeptides","display_name":"organic anion transporting polypeptides","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.8252073526382446},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6434334516525269},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4209224581718445},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21283137798309326},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.16848024725914001},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22403250","doi":"https://doi.org/10.1158/0008-5472.22403250","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22403250","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legends_from_Influence_of_Drug_Formulation_on_OATP1B-Mediated_Transport_of_Paclitaxel/22403250/1/files/39849054.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22403250.v1","doi":"https://doi.org/10.1158/0008-5472.22403250.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22403250.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22403250","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_Legends_from_Influence_of_Drug_Formulation_on_OATP1B-Mediated_Transport_of_Paclitaxel/22403250","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22403250","doi":"https://doi.org/10.1158/0008-5472.22403250","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22403250","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_Legends_from_Influence_of_Drug_Formulation_on_OATP1B-Mediated_Transport_of_Paclitaxel/22403250/1/files/39849054.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361847928.pdf","grobid_xml":"https://content.openalex.org/works/W4361847928.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7160866172","https://openalex.org/W4392679743","https://openalex.org/W2028694954","https://openalex.org/W7118496518","https://openalex.org/W2000478673","https://openalex.org/W2072235727","https://openalex.org/W1997556730","https://openalex.org/W4361960986","https://openalex.org/W2066651895","https://openalex.org/W7125784658"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"61KB":[3]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}